Literature DB >> 25874809

Mechanism of Inactivation of Neuronal Nitric Oxide Synthase by (S)-2-Amino-5-(2-(methylthio)acetimidamido)pentanoic Acid.

Wei Tang1, Huiying Li2, Emma H Doud3, Yunqiu Chen3, Stephanie Choing1, Carla Plaza2, Neil L Kelleher3, Thomas L Poulos2, Richard B Silverman1.   

Abstract

Nitric oxide synthase (NOS) catalyzes the conversion of l-arginine to l-citrulline and the second messenger nitric oxide. Three mechanistic pathways are proposed for the inactivation of neuronal NOS (nNOS) by (S)-2-amino-5-(2-(methylthio)acetimidamido)pentanoic acid (1): sulfide oxidation, oxidative dethiolation, and oxidative demethylation. Four possible intermediates were synthesized. All compounds were assayed with nNOS, their IC50, KI, and kinact values were obtained, and their crystal structures were determined. The identification and characterization of the products formed during inactivation provide evidence for the details of the inactivation mechanism. On the basis of these studies, the most probable mechanism for the inactivation of nNOS involves oxidative demethylation with the resulting thiol coordinating to the cofactor heme iron. Although nNOS is a heme-containing enzyme, this is the first example of a NOS that catalyzes an S-demethylation reaction; the novel mechanism of inactivation described here could be applied to the design of inactivators of other heme-dependent enzymes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25874809      PMCID: PMC4431946          DOI: 10.1021/jacs.5b01202

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  37 in total

Review 1.  Blocking NO synthesis: how, where and why?

Authors:  Patrick Vallance; James Leiper
Journal:  Nat Rev Drug Discov       Date:  2002-12       Impact factor: 84.694

Review 2.  Mammalian nitric oxide synthases.

Authors:  D J Stuehr; O W Griffith
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1992

3.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase.

Authors:  R KITZ; I B WILSON
Journal:  J Biol Chem       Date:  1962-10       Impact factor: 5.157

4.  Nitric-oxide synthase assays.

Authors:  J M Hevel; M A Marletta
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 5.  The role of nitric oxide in cardiovascular diseases.

Authors:  Khalid M Naseem
Journal:  Mol Aspects Med       Date:  2005-01-24

6.  Nitric oxide synthase (NOS) in the trigeminal vascular system and other brain structures related to pain in rats.

Authors:  Roshni Ramachandran; Kenneth Beri Ploug; Anders Hay-Schmidt; Jes Olesen; Inger Jansen-Olesen; Saurabh Gupta
Journal:  Neurosci Lett       Date:  2010-08-22       Impact factor: 3.046

7.  Rhodium(I)-catalyzed addition of arylboronic acids to (benzyl-/arylsulfonyl)acetonitriles: efficient synthesis of (Z)-β-sulfonylvinylamines and β-keto sulfones.

Authors:  Gavin Chit Tsui; Quentin Glenadel; Chan Lau; Mark Lautens
Journal:  Org Lett       Date:  2010-12-13       Impact factor: 6.005

8.  Reconstitution of the second step in NO synthesis using the isolated oxygenase and reductase domains of macrophage NO synthase.

Authors:  D K Ghosh; H M Abu-Soud; D J Stuehr
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

9.  Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease.

Authors:  P J Norris; H J Waldvogel; R L Faull; D R Love; P C Emson
Journal:  Neuroscience       Date:  1996-06       Impact factor: 3.590

Review 10.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14
View more
  2 in total

1.  Interaction of CYP3A4 with Rationally Designed Ritonavir Analogues: Impact of Steric Constraints Imposed on the Heme-Ligating Group and the End-Pyridine Attachment.

Authors:  Eric R Samuels; Irina F Sevrioukova
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

2.  Rational Design of CYP3A4 Inhibitors: A One-Atom Linker Elongation in Ritonavir-Like Compounds Leads to a Marked Improvement in the Binding Strength.

Authors:  Eric R Samuels; Irina F Sevrioukova
Journal:  Int J Mol Sci       Date:  2021-01-16       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.